exRNAdisease

Entry Detail

---



General Information

Database ID: exR0275454 RNA Name: hsa-miR-22-3p RNA Type: miRNA Chromosome: chr17 Starnd: - Coordinate: Start Site(bp): 1713914 End Site(bp): 1713935 External Links: hsa-miR-22-3p

Disease Information

Disease Name: Advanced Adenoma Disease Category: Cancers MeSH ID: D000236 Type: Neoplasms/Neoplasms, Glandular and Epithelial Alias: Adenoma//Adenomas//Adenoma, Follicular//Adenomas, Follicular//Follicular Adenoma//Follicular Adenomas//Adenoma, Trabecular//Adenomas, Trabecular//Trabecular Adenoma//Trabecular Adenomas//Adenoma, Monomorphic//Adenomas, Monomorphic//Monomorphic Adenoma//Monomorphic Adenomas//Adenoma, Papillary//Adenomas, Papillary//Papillary Adenoma//Papillary Adenomas//Adenoma, Basal Cell//Adenomas, Basal Cell//Basal Cell Adenoma//Basal Cell Adenomas//Adenoma, Microcystic//Adenomas, Microcystic//Microcystic Adenoma//Microcystic Adenomas

Expression Detail

GEO ID: GSE25609 Description: Plasma microRNA profiling by microarray elucidates several candidate biomarkers for colorectal cancer screening Experimental Design: Cancer vs Control Case Disease Type: Advanced Adenoma Case Disease SubType: NA Case Sample: Advanced Adenoma Post surgery Control Sample: Control Number of Case: 20 Number of Control: 20 Number of Samples: 40

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand CCDC97 chr19 41310172 41324873 + AP1S1 chr7 101154456 101161596 + RCOR1 chr14 102592649 102730561 + RAB11FIP4 chr17 31391675 31538211 + PPIF chr10 79347469 79355334 + FBXL19 chr16 30923055 30948783 + FNBP4 chr11 47716494 47767443 - DCP1A chr3 53283429 53347586 - GDAP1 chr8 74321130 74488872 + WSB2 chr12 118032694 118062430 - ITGA5 chr12 54395261 54419266 - IRS2 chr13 109752695 109786583 - FOXP1 chr3 70952817 71583993 - TMEM179B chr11 62787402 62790400 + ETS1 chr11 128458761 128587558 - ATP2C1 chr3 130850595 131016712 + ZNF740 chr12 53180704 53195142 + CACUL1 chr10 118674167 118755249 - ATP6V0B chr1 43974487 43978295 + ACLY chr17 41866917 41930542 - CLASP1 chr2 121337776 121649587 - PRLR chr5 35048756 35230487 - PDPR chr16 70113626 70162537 + WWC2 chr4 183099257 183320777 + TAGLN chr11 117199370 117207464 + BCL9 chr1 147541501 147626216 + GLIS2 chr16 4314761 4339597 + GBF1 chr10 102245532 102382899 + PDSS1 chr10 26697701 26746798 + RANBP2 chr2 108719482 108785809 + miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0001699 chr7 40027197 40041630 + hsa_circ_0001414 chr4 56277780 56284152 + hsa_circ_0000733 chr17 1561546 1562030 - lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC021078.1 chr5 149494314 149504670 - AL360012.1 chr1 28648600 28648730 + MALAT1 chr11 65497688 65506516 + NEAT1 chr11 65422774 65445540 + NORAD chr20 36045618 36051018 - OIP5-AS1 chr15 41283990 41309737 + SNHG16 chr17 76557764 76565348 + Display:

Experiment Detail

GEO ID: GSE25609 Sample Source: Blood Source Fraction: Plasma Platform: GPL8179 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 826 Sample treatment protocol: Briefly, samples were centrifuged at 1,600×g for 10 min at 4 ºC to spin down blood cells, and plasma was transferred into new tubes, followed by further centrifugation at 16,000×g for 10 minutes at 4ºC to completely remove cellular components. RNA Extract protocol: NA RNA library preparation protocol: Biotinylated cDNA were prepared with the Illumina® TotalPrep™ RNA Amplification Kit (Ambion).

Reference

PMID: 23267864 Title: Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study Author: Gir¨¢ldez MD, Lozano JJ, Ram¨ªrez G, Hijona E, Bujanda L, Castells A, Gironella M Journal: Clin Gastroenterol Hepatol. 2013 Jun;11(6):681-8.e3. Description: We investigated whether plasma levels of miRNA can differentiate patients with CRC from healthy individuals. We also investigated whether plasma samples from patients with premalignant neoplastic lesions, such as advanced adenomas (AAs), also had a different expression pattern of miRNAs.